Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine vs Atropine plus Plano Lens for Amblyopia
NCT00315302Phase 3
Key facts
- Status
- Completed
- Start
- Feb 2005
- Primary completion
- Oct 2007
- Countries
- 1
- Sponsor
- Jaeb Center for Health Research
- Modality
- Classical Binding Small Molecules
- Drugs
- atropine
- Conditions
- amblyopia
01
Overview
Phase 3, randomised, open-label trial of atropine in amblyopia, sponsored by Jaeb Center for Health Research. Primary endpoint: Visual Acuity Mean Score in the Amblyopic Eye at 18 weeks. Started Feb 2005; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Endpoints
Primary
Visual Acuity Mean Score in the Amblyopic Eye
Beyond the preview
Go deeper on NCT00315302.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00315302.